Last updated on March 2019

RESET Trial - Part 1 (Followed by Reset Trial - Part 2) - A Phase 3 Trial in Subjects With Sj gren-Larsson Syndrome (SLS)

Brief description of study

A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Trial to Evaluate the Safety and Efficacy of ADX-102 1% Topical Dermal Cream in Subjects with Sjgren-Larsson Syndrome (SLS).

Clinical Study Identifier: NCT03445650

Find a site near you

Start Over

Yale University

New Haven, CT United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.